GSK E-Mails Reveal Specific Allegations Of Whistleblower In China
This article was originally published in PharmAsia News
Executive Summary
A series of e-mails passed to GlaxoSmithKline executives regarding its operations in China disclosed its problems as early as January of last year when a whistleblower reported alleging cash and expensive gifts given to influential physicians.